A few days after the film’s premiere, I had lunch with Squibb in her hotel room, and we talked about the movie, her ...

The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

Bristol Myers Squibb is storming ASCO 2025 with data from over 80 studies covering 20+ cancer types, showcasing its oncology ...

The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...

Bristol Myers Squibb is gearing up for its moment in the spotlight at the Bernstein 41st Annual Strategic Decisions ...

BMSCH opens a Same Day Services center for kids needing infusion therapies, backed by a $2.5M gift from the Bristol Myers ...

The stock's fall snapped a four-day winning streak.

My monthly update and commentary on the top dividend stock picks from the Barron's Better Bets list, May 2025 edition. Read ...

MIT researchers found a way to measure cell density quickly and accurately -- measuring up to 30,000 cells in a single hour.

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to ...

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein 41 st Annual Strategic ...

Recent findings regarding interferon and Janus kinase inhibition may hold clues to improving outcomes in patients with ...